Clinical Trial Update: Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate [Phase 3]

View source ↗

Summary

Phase 3 trial update for filgotinib in combination with methotrexate in adults with moderately to severely active rheumatoid arthritis who had an inadequate res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Filgotinib (filgotinib)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Gilead Sciences | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2021-01-19